Gregory Ferenstein
Gregory Ferenstein is a senior fellow in drug policy at Reason Foundation.
-
Why is Texas investigating Meta’s AI Studio for offering unlicensed therapy?
Texas Attorney General Ken Paxton launched an investigation into Meta’s Artificial Intelligence Studio to determine whether its chatbot platform misleads children.
-
Nevada’s ban on AI therapists highlights regulation based on fear rather than analysis
This legislative approach could stifle innovation, prevent change and improvement in products and services, and harm the residents of Nevada.
-
New York’s stalled AI bill would have blurred the line between disclosure and restriction
While pitched as a transparency measure, Assembly Bill 8595 would have set a new, unusually high bar for compliance.
-
Democrats pivot on AI: Less regulation, more redistribution
The focus of Sen. Mark Kelly’s “AI for America” plan departs from other federal artificial intelligence policy proposals introduced by Democrats.
-
Sen. Ted Cruz proposes federal regulatory sandbox to encourage AI innovation, development
The SANDBOX Act would allow innovators to obtain temporary regulatory waivers for artificial intelligence technologies from federal agencies.
-
A look at the White House’s pro-innovation artificial intelligence ‘action plan’
The White House's AI action plan represents a clear policy direction favoring rapid innovation and reduced regulatory oversight.
-
State psychedelics legalization and policy roundup — October 2025
Kentucky debates clinical ibogaine trials, Mississippi considers ibogaine, Massachusetts bill would decriminalize psilocybin, and more.
-
Colorado can lead on AI fairness without a regulatory straitjacket
There are evidence-based, market-oriented steps Colorado lawmakers could take in place of the state's existing artificial intelligence law.
-
Next steps after the Senate rejected an AI regulation moratorium
The Senate's compromise effort for a federal moratorium on state laws regulating AI may show the way toward a politically viable path.
-
State psychedelics legalization and policy roundup — August 2025
Arizona allocates funding for ibogaine research, Reason Foundation to testify at Mississippi informational hearing about ibogaine, and more.
-
Existing laws already fight AI housing discrimination—new state AI bills increase confusion
Misguided artificial intelligence regulatory efforts risk limiting innovation and sowing misunderstanding in many markets.
-
Vermont attempts to regulate political AI deepfakes
Vermont lawmakers have introduced Senate Bill S.23, a proposal aimed at curbing the use of AI-generated synthetic media in state elections.
-
New York’s RAISE Act expands executive power over AI at the expense of legislative oversight
New York is the latest in a growing number of states attempting to regulate artificial intelligence.
-
Congress, states explore AI tools to fight Medicare, Medicaid fraud
Continued investment in artificial intelligence may help agencies achieve more accurate oversight and reduce waste in public health care spending.
-
State psychedelics legalization and policy roundup — June 2025
While many good psychedelics reforms failed to pass, there were a few notable wins from 2025 state legislative sessions.
-
California’s Senate Bill 813 is a novel approach to AI safety
The bill’s approach may serve as a viable alternative to heavy-handed regulation, but lawmakers should proceed carefully.
-
Governor Polis signed Colorado’s restrictive AI law, but supports a federal moratorium on similar legislation
Governor Polis believes it would be best to have a strong national policy governing AI that supersedes state law.
-
California needs tech solutions, not just poorly defined AI regulations, to protect kids
California’s Assembly Bill 1064 attempts to regulate a problem—dangerous AI-driven attachments— without clear solutions.